Evaluation of Neuromuscular Disease in Adults Presenting with Dyspnea

Abstract

Neuromuscular disorders in adults can present with a wide array of clinical features and vary from acute life-threatening complications such as respiratory failure to slow progressive weakness and comorbidity. Common to most of these disorders are symptoms of weakness and dyspnea. Many patients with occult neuromuscular disorders will be evaluated for underlying cardiac and pulmonary disease by primary care and subspecialty providers and can experience delays in diagnosis due to challenges in attaining early neurological testing and recognizing vague symptoms as potentially arising from the neuromuscular apparatus. Additionally, many adults who develop neuromuscular disorders have concomitant cardiac or pulmonary disease and the presence of dyspnea or limitations in mobility are often attributed to these without pursuing further workup. We outline a review of neuromuscular diseases in adults and an approach to evaluation.

Keywords

dyspnea - neuromuscular - weakness - diagnostic

Publication History

Article published online:
31 March 2025

• References

• 1 American Thoracic Society. Dyspnea. Mechanisms, assessment, and management: a consensus statement. Am J Respir Crit Care Med 1999; 159 (01) 321-340
• 2 Levison LS, Blicher JU, Andersen H. Incidence and mortality of ALS: a 42-year population-based nationwide study. J Neurol 2024; 272 (01) 44
• 3 Carr AS, Cardwell CR, McCarron PO, McConville J. A systematic review of population based epidemiological studies in myasthenia gravis. BMC Neurol 2010; 10: 46
• 4 Mamarabadi M, Mauney S, Li Y, Aboussouan LS. Evaluation and management of dyspnea as the dominant presenting feature in neuromuscular disorders. Muscle Nerve 2024; 70 (05) 916-928
• 5 Hutchinson A, Pickering A, Williams P, Bland JM, Johnson MJ. Breathlessness and presentation to the emergency department: a survey and clinical record review. BMC Pulm Med 2017; 17 (01) 53
• 6 Stenson K, Chew S, Dong S, Heithoff K, Wang MJ, Rosenfeld J. Health care resource utilization and costs across stages of amyotrophic lateral sclerosis in the United States. J Manag Care Spec Pharm 2024; 30 (11) 1239-1247
• 7 Larkindale J, Yang W, Hogan PF. et al. Cost of illness for neuromuscular diseases in the United States. Muscle Nerve 2014; 49 (03) 431-438
• 8 Broaddus V. ed. Murray & Nadel's Textbook of Respiratory Medicine. 6th ed.. Philadelphia, PA: Elsevier; 2016
• 9 Steier J, Kaul S, Seymour J. et al. The value of multiple tests of respiratory muscle strength. Thorax 2007; 62 (11) 975-980
• 10 Laghi F, Tobin MJ. Disorders of the respiratory muscles. Am J Respir Crit Care Med 2003; 168 (01) 10-48
• 11 McCool FD, Manzoor K, Minami T. Disorders of the diaphragm. Clin Chest Med 2018; 39 (02) 345-360
• 12 Lechtzin N, Wiener CM, Shade DM, Clawson L, Diette GB. Spirometry in the supine position improves the detection of diaphragmatic weakness in patients with amyotrophic lateral sclerosis. Chest 2002; 121 (02) 436-442
• 13 Kokatnur L, Rudrappa M. Diaphragmatic palsy. Diseases 2018; 6 (01) 16
• 14 Benditt JO. Respiratory care of patients with neuromuscular disease. Respir Care 2019; 64 (06) 679-688
• 15 Fromageot C, Lofaso F, Annane D. et al. Supine fall in lung volumes in the assessment of diaphragmatic weakness in neuromuscular disorders. Arch Phys Med Rehabil 2001; 82 (01) 123-128
• 16 American Thoracic Society/European Respiratory Society. ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med 2002; 166 (04) 518-624
• 17 Richard B. ed. Sleep and Respiratory Physiology, Fundamentals of Sleep Medicine. Philadelphia, PA: W.B. Saunders; 2012: 141-157
• 18 Bruschi C, Cerveri I, Zoia MC. et al. Reference values of maximal respiratory mouth pressures: a population-based study. Am Rev Respir Dis 1992; 146 (03) 790-793
• 19 Minami T, Manzoor K, McCool FD. Assessing diaphragm function in chest wall and neuromuscular diseases. Clin Chest Med 2018; 39 (02) 335-3
• 20 Georges M, Perez T, Rabec C. et al. Proposals from a French expert panel for respiratory care in ALS patients. Respir Med Res 2022; 81: 100901
• 21 Brennan M, McDonnell MJ, Duignan N, Gargoum F, Rutherford RM. The use of cough peak flow in the assessment of respiratory function in clinical practice- a narrative literature review. Respir Med 2022; 193: 106740
• 22 Dubé BP, Dres M. Diaphragm dysfunction: diagnostic approaches and management strategies. J Clin Med 2016; 5 (12) 113
• 23 Chetta A, Rehman AK, Moxham J, Carr DH, Polkey MI. Chest radiography cannot predict diaphragm function. Respir Med 2005; 99 (01) 39-44
• 24 Hoffman RJ, Garner HW, Rojas CA. et al. Atypical causes of dyspnea: a review of neuromuscular and chest wall disorders that compromise ventilation. J Thorac Imaging 2022; 37 (04) W45-W55
• 25 Harlaar L, Ciet P, van der Ploeg AT. et al. Imaging of respiratory muscles in neuromuscular disease: a review. Neuromuscul Disord 2018; 28 (03) 246-256
• 26 Fyles F, FitzMaurice TS, Robinson RE, Bedi R, Burhan H, Walshaw MJ. Dynamic chest radiography: a state-of-the-art review. Insights Imaging 2023; 14 (01) 107
• 27 Uchida S, Matsunaga T, Hattori A, Fukui M, Takamochi K, Suzuki K. Efficacy of dynamic chest radiography for evaluating surgical treatment of diaphragmatic paralysis. Ann Thorac Surg Short Rep 2024; 2 (03) 502-505
• 28 Liu X, Yang Y, Jia J. Respiratory muscle ultrasonography evaluation and its clinical application in stroke patients: a review. Front Neurosci 2023; 17: 1132335
• 29 Lallement P, Boussuges A, Habert P. et al. Evaluation of computed tomography in the diagnosis of ultrasound-proven diaphragm dysfunction. Respir Res 2024; 25 (01) 135
• 30 Santana PV, Cardenas LZ, Albuquerque ALP, Carvalho CRR, Caruso P. Diaphragmatic ultrasound: a review of its methodological aspects and clinical uses. J Bras Pneumol 2020; 46 (06) e20200064
• 31 Barroso de Queiroz Davoli G, Bartels B, Mattiello-Sverzut AC, Takken T. Cardiopulmonary exercise testing in neuromuscular disease: a systematic review. Expert Rev Cardiovasc Ther 2021; 19 (11) 975-991
• 32 Kim SH, Choi Y, Oh EK. et al. Profiling of anti-signal-recognition particle antibodies and clinical characteristics in South Korean patients with immune-mediated necrotizing myopathy. J Clin Neurol 2025; 21 (01) 31-39
• 33 Shah D. et al. Value of diaphragm electromyography and phrenic nerve conduction studies in suspected diaphragm paresis (P5-13.005). Neurology 2022; 98 (18) 634
• 34 Sarwal A, Walker FO, Cartwright MS. Neuromuscular ultrasound for evaluation of the diaphragm. Muscle Nerve 2013; 47 (03) 319-329
• 35 Dow DE, Zhan WZ, Sieck GC, Mantilla CB. Correlation of respiratory activity of contralateral diaphragm muscles for evaluation of recovery following hemiparesis. Annu Int Conf IEEE Eng Med Biol Soc 2009; 2009: 404-407